|
Digital histopathology-based multimodal artificial intelligence scores predict risk of progression in a randomized phase III trial in patients with nonmetastatic castration-resistant prostate cancer. |
| |
|
Stock and Other Ownership Interests - Artera; Bluestar Genomics; Serimmune |
Consulting or Advisory Role - Artera; Astellas Pharma; Bayer; BlueStar Genomics; Bristol Myers Squibb; Bristol Myers Squibb (BMS); Exact Sciences; Foundation Medicine; Janssen Biotech; Myovant Sciences; Novartis; POINT Biopharma; Roivant; SerImmune; Tempus; Varian Medical Systems |
Research Funding - Zenith Epigenetics |
| |
|
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Janssen Oncology; Lilly; Novartis; Pfizer |
Research Funding - Bayer (Inst); ESSA (Inst); Janssen Oncology (Inst); Lilly (Inst); ORIC Pharmaceuticals (Inst) |
| |
|
Honoraria - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; BMS; Janssen Oncology; Knight Therapeutics; Merck; Myovant Sciences; Novartis; Pfizer; Sanofi |
Consulting or Advisory Role - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca/MedImmune; Bayer; Janssen Oncology; Knight Therapeutics; Myovant Sciences; Novartis; Pfizer; Sanofi |
Research Funding - Advanced Accelerator Applications (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst) |
| |
|
Employment - Janssen Research & Development |
Patents, Royalties, Other Intellectual Property - Janssen Research & Development |
Travel, Accommodations, Expenses - Janssen Research & Development |
| |
|
Employment - Janssen Research & Development |
Stock and Other Ownership Interests - Johnson & Johnson |
Patents, Royalties, Other Intellectual Property - Patent for making cell blocks in cytology. |
Travel, Accommodations, Expenses - Janssen Oncology |
| |
|
Employment - Janssen Research & Development |
Stock and Other Ownership Interests - Johnson & Johnson |
| |
|
No Relationships to Disclose |
| |
|
Employment - Johnson & Johnson |
Leadership - Johnson & Johnson |
Stock and Other Ownership Interests - Johnson & Johnson |
Research Funding - Johnson & Johnson |
Travel, Accommodations, Expenses - Johnson & Johnson |
| |
|
Employment - Janssen Oncology |
Stock and Other Ownership Interests - Johnson & Johnson |
| |
|
Employment - Janssen Oncology |
Stock and Other Ownership Interests - Johnson and Johnson |
| |
|
Employment - Janssen Research & Development |
Leadership - Janssen Research & Development |
Stock and Other Ownership Interests - Johnson & Johnson |
Honoraria - Wellster Healthtech Group |
Consulting or Advisory Role - Wellster Healthtech Group |
Patents, Royalties, Other Intellectual Property - Founder of Vitruvo eHealth and Developer of a Digital Medicine Application |
| |
|
|
| |
|
|
| |
|
|
| |
|
Employment - Artera; Flatiron Health |
| |
|
|
| |
|
|
|
Stock and Other Ownership Interests - Artera |
Patents, Royalties, Other Intellectual Property - Artera's founding IP - multi-modal AI technology for cancer therapy personalization, using digital pathology. |
Travel, Accommodations, Expenses - Artera |
| |
|
Stock and Other Ownership Interests - Fortis; Harpoon Therapeutics; Teon Therapeutics |
Honoraria - Janssen; Johnson and Johnson |
Consulting or Advisory Role - Fortis; Janssen Oncology; Teon Therapeutics |